BIOMAT Database Logo BIOMAT Database Logo

Solution structure of the Ras-binding domain of c-Raf-1 and identification of its Ras interaction surface. 1995

S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Roche Research Center, Hoffmann-La Roche Inc., Nutley, New Jersey 07110, USA.

The structure of the Ras-binding domain of human c-Raf-1 (residues 55-132) has been determined in solution by nuclear magnetic resonance (NMR) spectroscopy. Following complete assignment of the backbone and side-chain 1H, 15N, and 13C resonances, the structure was calculated using the program CHARMM. Over 1300 NOE-derived constraints were applied, resulting in a detailed structure. The fold of Raf55-132 consists of a five-stranded beta-sheet, a 12-residue alpha-helix, and an additional one-turn helix. It is similar to those of ubiquitin and the IgG-binding domain of protein G, although the three proteins share very little sequence identity. The surface of Raf55-132 that interacts with Ras has been identified by monitoring perturbation of line widths and chemical shifts of 15N-labeled Raf55-132 resonances during titration with unlabeled Ras-GMPPNP. The Ras-binding site is contained within a spatially contiguous patch comprised of the N-terminal beta-hairpin and the C-terminal end of the alpha-helix.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D018631 ras Proteins Small, monomeric GTP-binding proteins encoded by ras genes (GENES, RAS). The protooncogene-derived protein, PROTO-ONCOGENE PROTEIN P21(RAS), plays a role in normal cellular growth, differentiation and development. The oncogene-derived protein ONCOGENE PROTEIN P21(RAS) can play a role in aberrant cellular regulation during neoplastic cell transformation (CELL TRANSFORMATION, NEOPLASTIC). This enzyme was formerly listed as EC 3.6.1.47. Gene Products, ras,ras GTPase,ras Protein,ras GTPases,GTPase, ras,GTPases, ras,Protein, ras,ras Gene Products
D019908 Proto-Oncogene Proteins c-raf A ubiquitously expressed raf kinase subclass that plays an important role in SIGNAL TRANSDUCTION. The c-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2. c-raf Proteins,Kinase Raf-1,Kinase p74(raf-1),Proto-Oncogene Protein c-raf,c-raf Kinases,cRaf1 Kinase,raf-1 Kinase,Kinase Raf 1,Kinase, cRaf1,Kinase, raf-1,Kinases, c-raf,Protein c-raf, Proto-Oncogene,Proteins c-raf, Proto-Oncogene,Proteins, c-raf,Proto Oncogene Protein c raf,Proto Oncogene Proteins c raf,Raf-1, Kinase,c raf Kinases,c raf Proteins,c-raf, Proto-Oncogene Protein,c-raf, Proto-Oncogene Proteins,raf 1 Kinase

Related Publications

S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site.
August 1996, Proceedings of the National Academy of Sciences of the United States of America,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
April 1995, Oncogene,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Identification of residues in the cysteine-rich domain of Raf-1 that control Ras binding and Raf-1 activity.
August 1998, The Journal of biological chemistry,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Transient kinetic studies on the interaction of Ras and the Ras-binding domain of c-Raf-1 reveal rapid equilibration of the complex.
October 1998, Biochemistry,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Cell-free synthesis of the Ras-binding domain of c-Raf-1: binding studies to fluorescently labelled H-ras.
June 1999, FEBS letters,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Solution structure of the Ras-binding domain of RGL.
December 1998, FEBS letters,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
A small peptide derived from the aminoterminus of c-Raf-1 inhibits c-Raf-1/Ras binding.
January 1995, Biochemical and biophysical research communications,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
KRAS interaction with RAF1 RAS-binding domain and cysteine-rich domain provides insights into RAS-mediated RAF activation.
February 2021, Nature communications,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Characterization of a 78-residue fragment of c-Raf-1 that comprises a minimal binding domain for the interaction with Ras-GTP.
September 1994, The Journal of biological chemistry,
S D Emerson, and V S Madison, and R E Palermo, and D S Waugh, and J E Scheffler, and K L Tsao, and S E Kiefer, and S P Liu, and D C Fry
Solution structure of the Ran-binding domain 2 of RanBP2 and its interaction with the C terminus of Ran.
May 2005, Journal of molecular biology,
Copied contents to your clipboard!